Miotox

Miotox LLC is a biopharmaceutical intellectual property company based in Beverly Hills, California, founded by Dr. William J. Binder. The company is best known for discovering and patenting the use of botulinum toxin type A (Botox) for the treatment of migraine headaches, a breakthrough that led to a significant licensing partnership with Allergan (now AbbVie). Miotox holds a portfolio of patents covering various methods of administration and indications for neurotoxins, including chronic migraine and post-traumatic headache. The company is actively engaged in clinical research to expand the therapeutic applications of botulinum toxin to conditions such as traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). Miotox is also recognized for its high-profile legal efforts to protect its intellectual property and ensure fair royalty compensation from its pharmaceutical partners.